rac-Rotigotine-D3 Methyl Ether is a labelled analog of (S)-5-Methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine (CAT# S072685), which is a related compound of Rotigotine (CAT# S118315), a non-???ergolinic dopamine agonist used in the treatment of Parkinson's disorder and restless legs syndrome.Intermediate in the production of labelled Rotigotine
References: Sravanthi, A., et al.: Int. J. Pharm. Sci. Rev. Res., 66, 11 (2021)
{{ product.accreditations.length <= 2 ? product.accreditations[0].name : product.accreditations.map(e => e.name).join(', ') }} Accredited within the boundaries of LGC’s fixed and flexible scope of UKAS accreditation. Further details can be found in the scheme description. ISO/IEC 17043 Specifies general requirements for the competence of providers of proficiency testing schemes and for the development and operation of proficiency testing schemes. Find out more.
